Recombinant human granulocyte colony stimulating Factor (Beijing Four Rings Bio-Pharmaceutical)

重组人粒细胞刺激因子（北京四环生物制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human granulocyte colony stimulating Factor (Beijing Four Rings Bio-Pharmaceutical)
Drug Alias Name欣粒生Xin Lisheng
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2002/06/17
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Four Rings Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Four Rings Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A